{
  "ptid_time": "131_S_0123_2011-03-08",
  "img_path": "/data/qiuhui/data/adni/images/131_S_0123/2011-03-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,888 mm³, 4.2% below the reference mean. With a Z-score of -0.10 (46.0th percentile), this represents normal volume ; hippocampal volume measures 5,236 mm³, 30.7% below the reference mean. With a Z-score of -3.00 (0.1th percentile), this represents significant atrophy; whole brain volume measures 851,182 mm³, 21.1% below the reference mean. With a Z-score of -2.74 (0.3th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,653 mm³, 35.3% below the reference mean. With a Z-score of -2.39 (0.8th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,921 mm³, 26.1% below the reference mean. With a Z-score of -2.22 (1.3th percentile), this represents significant atrophy; middle temporal gyrus volume measures 13,769 mm³, 35.5% below the reference mean. With a Z-score of -3.19 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 78.3 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 30.0. MoCA: 28.0. Logical Memory: 22.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.05 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus) with Z-scores ≤ -2.22 (≤1.3th percentile), suggesting neurodegenerative pathology. However, cognitive scores (MMSE 30, MoCA 28) are intact, and amyloid PET (AV45) is normal, making typical Alzheimer’s unlikely.  \n**Diagnosis:** **MCI** (structural atrophy without cognitive decline or amyloid positivity may suggest non-AD pathology or pre-symptomatic neurodegeneration).  \n**Confidence:** **Medium** (discordance between imaging and clinical/biomarker data warrants caution).  \n\n*Note: Consider non-AD etiologies (e.g., primary age-related tauopathy, hippocampal sclerosis) or longitudinal follow-up to clarify progression.*",
  "timestamp": "2025-07-26T14:59:37.748144"
}